Martin G S
Vanderbilt University Medical Center, Nashville, Tennessee 37232-2650, USA.
Crit Care. 2000;4 Suppl 2(Suppl 2):S21-5. doi: 10.1186/cc966. Epub 2000 Oct 13.
Available evidence suggests that both hydrostatic and osmotic forces are important in the development of acute respiratory distress syndrome (ARDS) or, more broadly, acute lung injury (ALI). More than 80% of ARDS patients in a large-scale randomized controlled trial (RCT) exhibited, at least intermittently, pulmonary artery wedge pressures (PAWP) above 18 mmHg. Retrospective analyses have shown that PAWP elevation is associated with increased mortality. Reduction in serum total protein (STP) has been shown, in a recent retrospective analysis of data from a sepsis patient population with a high frequency of ARDS, to be highly predictive of positive fluid balance, weight gain, development of ARDS, prolonged mechanical ventilation, and mortality. These findings suggest that therapy with diuretics and colloids might be of benefit in the prevention or treatment of ALI. A prospective RCT was designed and conducted to evaluate combination therapy with furosemide and albumin over a 5-day period in 37 ALI patients. Both mean serum albumin and mean STP increased promptly and substantially in furosemide + albumin recipients. The furosemide + albumin group also achieved a mean weight loss of 10 kg by the end of the treatment phase, and their weight loss exceeded that of placebo patients throughout. Hemodynamics improved in the treatment group during the 5-day protocol. Oxygenation, as assessed by the ratio between the fraction of inspired oxygen and the partial pressure of oxygen in arterial blood (PaO2/FiO2), was significantly higher within 24 h after commencement of treatment in the furosemide + albumin than the placebo group. No clinically important adverse effects of furosemide + albumin therapy were encountered. These results provide evidence that combined therapy with furosemide and albumin is effective in augmenting serum albumin and STP levels, promoting weight loss, and improving oxygenation and longer-term hemodynamic stability. Although mortality did not differ between groups, the RCT showed a trend toward reduced duration of mechanical ventilation and length of stay in the intensive care unit in patients receiving furosemide + albumin. The findings of the RCT further highlight the importance of both hydrostatic and osmotic forces in hypoxemic respiratory failure, a subject that requires further investigation.
现有证据表明,静水压和渗透压在急性呼吸窘迫综合征(ARDS)或更广泛的急性肺损伤(ALI)的发生发展中都很重要。在一项大规模随机对照试验(RCT)中,超过80%的ARDS患者至少间歇性地出现肺动脉楔压(PAWP)高于18 mmHg。回顾性分析表明,PAWP升高与死亡率增加相关。最近一项对ARDS高发的脓毒症患者群体数据的回顾性分析显示,血清总蛋白(STP)降低高度预示着正液体平衡、体重增加、ARDS的发生、机械通气时间延长和死亡率。这些发现表明,利尿剂和胶体治疗可能有助于预防或治疗ALI。设计并进行了一项前瞻性RCT,以评估37例ALI患者在5天内使用呋塞米和白蛋白的联合治疗。接受呋塞米+白蛋白治疗的患者,平均血清白蛋白和平均STP均迅速且显著升高。到治疗阶段结束时,呋塞米+白蛋白组的平均体重减轻了10 kg,且整个过程中他们的体重减轻超过了安慰剂组患者。在为期5天的治疗方案中,治疗组的血流动力学得到改善。通过吸入氧分数与动脉血氧分压(PaO2/FiO2)之比评估的氧合情况,在呋塞米+白蛋白组治疗开始后24小时内显著高于安慰剂组。未发现呋塞米+白蛋白治疗有临床上重要的不良反应。这些结果证明,呋塞米和白蛋白联合治疗在提高血清白蛋白和STP水平、促进体重减轻、改善氧合以及长期血流动力学稳定性方面是有效的。尽管两组之间死亡率无差异,但RCT显示,接受呋塞米+白蛋白治疗的患者机械通气时间和重症监护病房住院时间有缩短趋势。RCT的结果进一步凸显了静水压和渗透压在低氧性呼吸衰竭中的重要性,这一主题需要进一步研究。